CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Chinese traditional medicine firm Neautus jumps in Hong Kong debut

By Reuters News

HONG KONG, Nov 11 (Reuters) - Shares of Sichuan Neautus Traditional Chinese Medicine 2206.HK jumped as much as 119.2% in their Hong Kong market debut on Wednesday after the company raised HK$262 million ($33.4 million) in an initial public offering.


• The shares of the Chinese traditional medicine manufacturer opened at HK$51.3, up 27.6% from their HK$40.20 offer price, and hit a high of HK$88.1. The stock last traded at HK$83, still up 106.5% from offer price. Hang Seng Index .HSI was down 0.7%

• Neautus sold 6.52 million shares at the bottom of the HK$40.20 to HK$50.55 price range. The retail portion was 2,190.99 times subscribed, while the international offering was 1.25 times subscribed

• The company said it plans to expand and automate production, develop wellness products, widen sales in China, Vietnam and Malaysia, and fund working capital

($1 = 7.8429 Hong Kong dollars)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.